BioRestorative Therapies, Inc. (BRTX)
NASDAQ: BRTX · Real-Time Price · USD
1.170
-0.026 (-2.17%)
Jan 6, 2026, 4:00 PM EST - Market closed
BioRestorative Therapies Employees
BioRestorative Therapies had 11 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
11
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$34,855
Profits / Employee
-$1,151,862
Market Cap
10.39M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 11 | 0 | - |
| Dec 31, 2023 | 11 | 1 | 10.00% |
| Dec 31, 2022 | 10 | 3 | 42.86% |
| Dec 31, 2021 | 7 | 2 | 40.00% |
| Dec 31, 2020 | 5 | -1 | -16.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BRTX News
- 7 weeks ago - BioRestorative Therapies, Inc. (BRTX) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BioRestorative Therapies to Report Third Quarter 2025 Financial Results and Host Conference Call on November 12, 2025 - GlobeNewsWire
- 2 months ago - BioRestorative Awarded Notice of Allowance for Japanese Patent – Expands Protection for Potential Cell-Based Alternative to Multi-Billion Dollar GLP-1 Drug Market - GlobeNewsWire
- 2 months ago - BioRestorative Strengthens Commercial Leadership with Appointment of Crystal Romano as Head of Global Commercial Operations to Accelerate Growth of Cell-Based Product Portfolio - GlobeNewsWire
- 2 months ago - BioRestorative Therapies to Participate in the 2025 Maxim Growth Summit - GlobeNewsWire
- 3 months ago - BioRestorative CEO Lance Alstodt Interviewed on “The Big Biz Show” - GlobeNewsWire
- 3 months ago - BioRestorative Therapies Announces $1.085 Million Registered Direct Offering Priced Above Market - GlobeNewsWire
- 5 months ago - BioRestorative Therapies, Inc. (BRTX) Q2 2025 Earnings Call Transcript - Seeking Alpha